| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |